Company intelligence / Profile preview

Bioyond Robotics

Shanghai, Shanghai Municipality, Chinabioyond.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Bioyond Robotics has developed three core technology platforms—robotics, automation, and data/cloud—to deliver flexible modular laboratory automation solutions. These are widely adopted by over 100 leading life sciences companies for applications ranging from small molecule drug discovery to biologics development and clinical diagnostics. The company is recognized as an outperformer in the drug analytical chemistry platforms market.

Modalities: Small moleculeBiologicCell therapyGene therapySynthetic biology research
Industry: Drug Discovery Services

Partnerships

Serves over 100 well-known life science enterprises globallyLilly Asia Fund (investor)

Beyond the preview

Go deeper on Bioyond Robotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioyond Robotics.

Explore the full profile